Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Learn why index funds are a popular choice for retirement, offering broad market exposure, low fees, and straightforward, scalable strategy.
24,587 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Tesla is steering its $25 billion capex plan beyond cars and into AI and robotics. This shift could transform margins...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
A major biotech acquisition news drove a sharp move in ATAI shares. This article breaks down why ataibeckley stock so...
DocMagic promotes Leah Sommerville to director of sales, signaling a bold push toward enterprise-wide paperless closi...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
Florida advances a bill to license stablecoin issuers and oversee the market at the state level, signaling a potentia...
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
New York Fed researchers find a widening gap in how households respond to rising gas prices after the Iran-related sh...
The phrase oklo stock sinking today captures the mood around Oklo’s latest earnings and market reaction. This guide b...
Dell stocks jumped ahead this week as rival Lenovo signals hint at broader hardware demand. This guide breaks down wh...
In May, Marvell Technology delivered more than a beat on sentiment, aided by AI infrastructure demand and a strategic...